Premature Mortality due to Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, and Leukemia in Canada: A Nationwide Analysis from 1980 to 2015.

In this study, we applied this novel measure to examine trends in premature mortality caused by hematological cancers in Canada from 1980 to 2015. Mortality data for Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma, and leukemia were obtained from the World Health Organization mortality database. Years of life lost was calculated according to Canadian life tables. ALSS was defined as the ratio between years of life lost and expected lifespan. Over the study period, age standardized rates of mortality decreased for all types of hematological cancers. Our new ALSS measure showed favorable trends in premature mortality for all types of hematological cancers among both sexes. For instance, men with non-Hodgkin's lymphoma lost an average of 23.7% of their lifespan in 1980 versus 16.1% in 2015, while women with non-Hodgkin's lymphoma lost an average of 21.7% of their lifespan in 1980 versus 15.5% in 2015. Results from this study showed that patients with hematological cancers experienced prolonged survival over a 35-year period although the magnitude of these lifespan gains varied by types of hematological cancers. PMID: 32706884 [PubMed - as supplied by publisher]
Source: Am J Epidemiol - Category: Epidemiology Authors: Tags: Am J Epidemiol Source Type: research